Opens in a new tab

RESEARCHER VERIFICATION:

Lionheart Peptides sells premium research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use – not for human or animal consumption.

All products on this website are sold strictly for Research Use Only – not for human, animal, clinical, or therapeutic use. Customers are responsible for compliant, properly authorized handling of all products and associated risks.

P-21

Regular Price$78.40

Neurogenic peptide for brain and neuroplasticity research

P-21 (P021) is a peptide studied in laboratory research involving neuronal growth, neuroplasticity, and brain-related cellular pathways. Derived from Cerebrolysin, it is investigated for its relationship with Ciliary Neurotrophic Factor (CNTF) and processes associated with neuronal function.

Key Product Facts

  • CAS No.: 146751-68-7
  • Molecular Formula: C27H42N6O8
  • Molecular Weight: 564.29 g/mol
  • Appearance: White Powder
  • Storage: 2–8°C
  • Purity: ≥99% stated purity

We accept

Payments method
/ 01 — Product Overview

About P-21

P-21, also known as P021, is a neurogenic peptide derived from Cerebrolysin. Laboratory research investigates the compound in relation to CNTF signaling, neuronal growth, neuroplasticity, and other cellular pathways associated with brain function.

Key Highlights

  • Also known as P021
  • Neurogenic peptide
  • Derived from Cerebrolysin
  • Studied in neuronal growth research
  • Investigated in neuroplasticity pathways
  • Research involving Ciliary Neurotrophic Factor (CNTF)
  • 10mg size
  • ≥99% stated purity
  • White powder
  • Storage at 2–8°C

What’s Included

  • 1 vial of P-21
  • 10mg
/ 02 - Additional Details

Additional Details

Specifications

CAS No.: 146751-68-7
Molecular Formula: C27H42N6O8
Molecular Weight: 564.29 g/mol
Appearance: White Powder
Storage: 2–8°C
Purity: ≥99%

Research Use Notice

All products featured here are intended exclusively for research and development purposes. They are not designed for human or animal consumption and have not undergone evaluation by the U.S. Food and Drug Administration.